Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

40.95
-1.1100-2.64%
Post-market: 40.950.00000.00%19:30 EDT
Volume:466.46K
Turnover:19.26M
Market Cap:1.54B
PE:-40.98
High:42.70
Open:42.50
Low:40.81
Close:42.06
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:0.82
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:101.00
PE(LYR):-292.50

Loading ...

BRIEF-Harrow To Initiate Phase 3 Clinical Trial Seeking To Expand Triesence® Label To Include Ocular Inflammation And Pain Following Cataract Surgery Indication

Reuters
·
Mar 03

Harrow announces U.S. FDA cleared an IND application for trial of Triesence

TIPRANKS
·
Mar 03

FDA clears Harrow IND for Phase 3 TRIESENCE cataract surgery trial

Reuters
·
Mar 03

Harrow Inc - to Initiate Phase 3 Study in Q1 2026

THOMSON REUTERS
·
Mar 03

BUZZ-Drugmaker Harrow slumps after forecasting annual revenue below estimates

Reuters
·
Mar 03

Stock Track | Harrow Health Plunges 15.66% in Pre-Market on Earnings Miss and Weak 2026 Guidance

Stock Track
·
Mar 03

Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX) and Harrow Health (HROW)

TIPRANKS
·
Mar 03

Stock Track | Harrow Health Plunges 13.25% Post-Market on Earnings Miss and Weak 2026 Guidance

Stock Track
·
Mar 03

Harrow Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Mar 03

Harrow Q4 EPS $0.17 Misses $0.38 Estimate, Sales $89.092M Beat $88.447M Estimate

Benzinga Earnings
·
Mar 03

Harrow sees FY26 revenue $350M-$365M, consensus $386.39M

TIPRANKS
·
Mar 03

Stock Track | Harrow Health Plunges 10.43% After-Hours on Earnings Miss and Weak Guidance

Stock Track
·
Mar 03

Earnings Flash (HROW) Harrow Posts Q4 EPS $0.17, vs. FactSet Est of $0.37

MT Newswires Live
·
Mar 03

Harrow Q4 revenue slightly beats estimates

Reuters
·
Mar 03

Harrow posts FY 2025 revenue of USD 272.3 million, up 36%

Reuters
·
Mar 03

BRIEF-Harrow Inc Q4 Gross Margin 79%

Reuters
·
Mar 03

Harrow Inc Q4 EPS USD 0.17

THOMSON REUTERS
·
Mar 03

Harrow Inc - Expects 2026 Adj Ebitda Between $80 Mln and $100 Mln

THOMSON REUTERS
·
Mar 03

Harrow Inc Outlook FY Revenue $350 Million to $365 Million

THOMSON REUTERS
·
Mar 03

Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

THOMSON REUTERS
·
Mar 03